2020
DOI: 10.1038/s41401-020-0459-6
|View full text |Cite
|
Sign up to set email alerts
|

GJA1-20k attenuates Ang II-induced pathological cardiac hypertrophy by regulating gap junction formation and mitochondrial function

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
16
0

Year Published

2021
2021
2025
2025

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(16 citation statements)
references
References 59 publications
0
16
0
Order By: Relevance
“…It is possible that the reason a central mediator of preconditioning has not been determined is that it has not been available for study. GJA1-20k was only first reported to occur endogenously in 2013 ( Smyth and Shaw, 2013 ) and its association with mitochondria and potential beneficial effects for survival of I/R was reported in the last 3 years ( Fu et al, 2017 ; Basheer et al, 2018 ; Wang et al, 2019 ; Fu et al, 2020 ; Ren et al, 2020 ). As a smaller isoform of Cx43 that contains the epitope of most anti-Cx43 antibodies, and is localized to mitochondria ( Fu et al, 2017 ), GJA1-20k could be central to the studies that implicated Cx43 as a mediator of preconditioning.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…It is possible that the reason a central mediator of preconditioning has not been determined is that it has not been available for study. GJA1-20k was only first reported to occur endogenously in 2013 ( Smyth and Shaw, 2013 ) and its association with mitochondria and potential beneficial effects for survival of I/R was reported in the last 3 years ( Fu et al, 2017 ; Basheer et al, 2018 ; Wang et al, 2019 ; Fu et al, 2020 ; Ren et al, 2020 ). As a smaller isoform of Cx43 that contains the epitope of most anti-Cx43 antibodies, and is localized to mitochondria ( Fu et al, 2017 ), GJA1-20k could be central to the studies that implicated Cx43 as a mediator of preconditioning.…”
Section: Discussionmentioning
confidence: 99%
“…Endogenous induction of GJA1-20k may also explain other instances when smaller mitochondrial size correlates with a beneficial effect ( Coronado et al, 2018 ). Recent studies have identified that exogenous GJA1-20k can protect neurons subjected to traumatic brain injury ( Ren et al, 2020 ), hearts from ischemia ( Basheer et al, 2018 ) and angiotensin induced hypertrophy ( Fu et al, 2020 ). Furthermore, by mimicking the protection afforded by ischemic preconditioning, exogenous GJA1-20k is a promising therapeutic to protect hearts, brains and other organs against expected ischemic damage.…”
Section: Discussionmentioning
confidence: 99%
“…Inhibition of mTOR signaling increases expression of GJA1-20k via inhibition of capdependent protein translation to facilitate trafficking of the full-length isoform to the cell membrane [276]. GJA1-20k overexpression increases formation of Cx43 gap junctions, enhances mitochondrial biogenesis, and reduces ROS levels despite increased mitochondrial membrane potential and increased oxygen consumption in angiotensin II-induced cardiomyocyte hypertrophy [281]. Mitochondrial Cx43 can inhibit mPTP opening, which reduces ROS release [282].…”
Section: Connexin 43mentioning
confidence: 99%
“…It is possible that the reason a central mediator of preconditioning has not been determined is that it has not been available for study. GJA1-20k was first reported to occur endogenously in 2013 (Smyth and Shaw, 2013) and its association with mitochondria and potential beneficial effects for survival of I/R was only reported in the last three years (Fu et al, 2017, Basheer et al, 2018, Fu et al, 2020, Ren et al, 2020, Wang et al, 2019. As a smaller isoform of Cx43 that contains the epitope of most anti-Cx43 antibodies, and is localized to mitochondria (Fu et al, 2017), GJA1-20k could be central to the studies that implicated Cx43 as a mediator of preconditioning.…”
Section: Discussionmentioning
confidence: 99%